课题基金 / 基金详情

Differences in cognitive and neuroimaging outcomes in elderly adults on angiotension converting enzyme (ACE) inhibitors versus angiotension receptive blockers (ARBs).

Differences in cognitive and neuroimaging outcomes in elderly adults on angiotension converting enzyme (ACE) inhibitors versus angiotension receptive blockers (ARBs).
血管紧张素转换酶（ACE）抑制剂与血管紧张素受体阻滞剂（ARB）在老年人认知和神经影像学结果上的差异。
批准号：
293807
负责人：
Black Sandra E
金额：
$7.29万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-10-01 至 2015-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=293807&lang=en
关键词：
Alzheimer'S Disease Angiotensin Converting Enzyme (Ace) Inhibitors Angiotensin Receptive Blockers (Arb) Atrophy And Hippocampal Volume Loss Beta Amyloid Cognitive Impairment Hypertension Multimodal Imaging Risk Modelling Small Vessel Disease

项目摘要

项目成果

Black Sandra E的其他基金

相关文献

中文摘要
翻译
阿尔茨海默病(AD)影响着全球超过3500万人。大约有75万加拿大人患有认知障碍或AD，这个数字预计在一代人内会翻一番。高血压是高血压发病的重要危险因素。
英文摘要
Alzheimer's disease (AD) affects more than 35 million people worldwide. Approximately 750,000 Canadians have cognitive impairment or AD, a number expected to double within a generation. High blood pressure is an important risk factor for the development o
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Small Vessel Disease meets protein misfolding: Phenobanking common dementias in clinical care to inform future precision medicine.
Understanding Neurodegeneration, Venules, Amyloid Imaging and Leukoaraiosis (UNVAIL)
Cohort to illuminate Neurodegeneration, Genetics, Imaging Associations and Leukoaraiosis (CONGENIAL)
In Vivo Brain Mapping in the Dementias: A Longitudinal Brain-Behaviour Study with a Focus on Cerebrovascular Disease and Heterogeneity